Sarepta Therapeutics
SRPT
SRPT
452 hedge funds and large institutions have $12.1B invested in Sarepta Therapeutics in 2020 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 125 increasing their positions, 160 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
1.62% less ownership
Funds ownership: 91.31% → 89.69% (-1.6%)
22% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 160
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
452
Holding in Top 10
5
Calls
$683M
Puts
$719M
Top Buyers
| 1 | +$175M | |
| 2 | +$59.1M | |
| 3 | +$44.9M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$41.4M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$37.1M |
Top Sellers
| 1 | -$151M | |
| 2 | -$93.8M | |
| 3 | -$69.1M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$63.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$52.7M |